Feed WILYY
WI

Demant A/S

WILYY · OTC

$23.14 +0.00% (+$0.00)
1M +7.83%
Market Cap 65.6B kr
P/E Ratio 42.45x
Div. Yield -
ROE 15.43%

Bulios Fair Price

$16.23

29.9% downside

Current Price

$23.14

Undervalued Fair Value Overvalued

According to Bulios Fair Price, WILYY is currently overvalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Strong
7/9
Valuation
39 /100
Fair
EV/EBITDA 15.88x
P/S 2.86x
P/B 6.66x
Growth
46 /100
Stable
Rev. growth 5.24%
FCF growth 23.20%
Book val. growth 4.76%
Profitability
76 /100
Strong
Net margin 6.73%
Op. margin 17.01%
FCF margin 13.82%
Quality
54 /100
Average
ROE 15.43%
ROA 3.95%
Asset turnover 0.59x
Debt
39 /100
Moderate
Current ratio 1.36x
Int. coverage 7.35x
Net debt/EBITDA 3.66x
Stability
87 /100
Stable
Rev. volatility 7.45%
EPS volatility 36.26%
Profitable years 6

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about WILYY
Online

Sector

Healthcare

Industry

Medical - Devices

CEO

Søren Nielsen

Employees

26,704

Headquarters

Smørum

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.